We could not find any results for:
Make sure your spelling is correct or try broadening your search.
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - HBP Canada NewsWire TORONTO, le 1er avril 2024 TORONTO, le 1er avril 2024 /CNW/...
Canadian Investment Regulatory Organization Trade Resumption - HBP Canada NewsWire TORONTO, April 1, 2024 TORONTO, April 1, 2024 /CNW/ - Trading resumes in: Company: Helix BioPharma Corp. TSX...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - HBP Canada NewsWire TORONTO, le 28 mars 2024 TORONTO, le 28 mars 2024 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - HBP Canada NewsWire TORONTO, March 28, 2024 TORONTO, March 28, 2024 /CNW/ - The following issues have been halted by CIRO: Company:...
RICHMOND HILL, Ontario, July 30, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer...
RICHMOND HILL, Ontario, July 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
RICHMOND HILL, Ontario, June 26, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in...
NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) -- Proactive, the digital financial news organization, will be showcasing four rising stars of the life sciences industry with its first North American...
RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
RICHMOND HILL, Ontario, June 11, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.7 | 0.74 | 0.57 | 46955 | 0.68278989 | CS |
4 | -0.4 | -36.3636363636 | 1.1 | 1.13 | 0.5 | 20408 | 0.71379317 | CS |
12 | -0.45 | -39.1304347826 | 1.15 | 1.34 | 0.5 | 10487 | 0.87890997 | CS |
26 | -0.35 | -33.3333333333 | 1.05 | 1.35 | 0.5 | 7678 | 0.97974971 | CS |
52 | -0.45 | -39.1304347826 | 1.15 | 1.35 | 0.5 | 10905 | 1.00769544 | CS |
156 | -1.775 | -71.7171717172 | 2.475 | 2.75 | 0.5 | 13600 | 1.13159563 | CS |
260 | -5.05 | -87.8260869565 | 5.75 | 10.05 | 0.5 | 17612 | 2.26202484 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions